Business
LDX & BARDA partner on new US$6.2m FebriDx Paediatric Study
LDX & BARDA partner on new US$6.2m FebriDx Paediatric Study

About this update from Lumos Diagnostics Holdings Ltd.
Lumos Diagnostics Holdings Ltd has released a press release. View Attachment
View stock analysis, news, and events for Lumos Diagnostics Holdings Ltd.